Endowed by the Federal Ministry of Science, Research and Economy and awarded by the Network of "Austrian Scientists and Scholars in North America" (ASCINA), the prize rewards outstanding scientific achievements of Austrians performed in the United States.

During the 13^th Austrian Research and Innovation Talk (ARIT), on October 22nd, 2016, in Toronto, Georg Winter, as well as two other Austrian scientists who worked in the USA, received the ASCINA award from Mag. MA Barbara Weitgruber, Director General for Scientific Research and International Relations, Austrian Federal Ministry of Science, Research and Economy. The prize, endowed with € 7500 in the category “Young Scientist”, goes to Austrians who spent at least twelve months in the USA, conducting excellent scientific research.

The award-winning publication of Georg Winter offers a promising new strategy for cancer therapy: Instead of inhibiting individual functions of a disease-relevant protein, his approach enabled the degradation of the whole molecule. The study was performed at the Dana Farber Cancer Institute of the Harvard Medical School, where Winter spent three years as a Postdoctoral fellow, and was published in Science.

In Summer 2016, Georg Winter has joined CeMM´s faculty as a Principal Investigator, focusing his research on chemical biology of oncogenic gene regulation. He continues his work on targeted protein degradation and is interested in understanding the molecular basis of aberrant gene regulation in cancer.

CeMM congratulates Georg Winter for receiving this prestigious award!

Publication: DRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein degradation. Winter GE, Buckley DL, Paulk J, Roberts JM, Souza A, Dhe-Paganon S, Bradner JE. Science. 2015 Jun 19;348(6241):1376-81. doi: 10.1126/science.aab1433.